Drug intelligence / Profile preview

18f-fluorodopamine

Development stage
Phase 1
Lead developer
St. Jude Children's Research Hospital
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

18f-fluorodopamine is a radiopharmaceutical and positron emission tomography (PET) imaging tracer that serves as a fluorine-18 labeled analogue of the neurotransmitter dopamine. It is specifically designed to visualize the sympathetic nervous system and neuroendocrine tissues. Mechanistically, 18f-fluorodopamine acts as a substrate for the norepinephrine transporter (NET), also known as Uptake-1, which facilitates its accumulation into the storage vesicles of sympathetic nerve endings and chromaffin cells. This targeted uptake makes it highly effective for the localization and staging of catecholamine-producing tumors, including pheochromocytomas, paragangliomas, and neuroblastomas. It is frequently compared to the conventional tracer 123I-MIBG, often demonstrating superior image resolution and sensitivity, particularly in the detection of metastatic disease.

Other names
6-18F-fluorodopamine6-fluoro-18F-dopaminefluorodopamine F 18
02

Targets

NET (Norepinephrine Transporter)

Beyond the preview

Go deeper on 18f-fluorodopamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 18f-fluorodopamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call